OCUL insider buying
OCULAR THERAPEUTIX, INC
Every qualifying open-market purchase of OCUL reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in OCUL yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in OCUL
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
OCUL insider buying — FAQ
- Are insiders buying OCUL stock?
- 2 insiders have bought OCUL (OCULAR THERAPEUTIX, INC) on the open market, most recently on Feb 24, 2026. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much OCUL stock have insiders bought?
- Insiders have bought a combined $531.0K of OCUL across 2 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in OCUL?
- A cluster buy is two or more distinct OCULAR THERAPEUTIX, INC insiders — officers, directors, or 10% owners — each buying OCUL on the open market within a rolling window. None has been detected in OCUL yet.
- Where does this OCUL insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in OCUL
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy OCUL within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding OCUL.